Perspective - Industry driven treatment of end-stage renal disease related hyperparathyroidism

    Activiteit: Professional or public presentationProfessional

    Periode2-nov.-2017
    Gehouden opJohnson & Johnson institute, Netherlands
    Mate van erkenningNational